BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 15453094)

  • 21. Design, synthesis, and binding studies of new potent ligands of cannabinoid receptors.
    Brizzi A; Brizzi V; Cascio MG; Bisogno T; Sirianni R; Di Marzo V
    J Med Chem; 2005 Nov; 48(23):7343-50. PubMed ID: 16279794
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prediction of essential binding domains for the endocannabinoid N-arachidonoylethanolamine (AEA) in the brain cannabinoid CB1 receptor.
    Shim JY
    PLoS One; 2021; 16(6):e0229879. PubMed ID: 34181638
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anandamide-induced endoplasmic reticulum stress and apoptosis are mediated by oxidative stress in non-melanoma skin cancer: Receptor-independent endocannabinoid signaling.
    Soliman E; Van Dross R
    Mol Carcinog; 2016 Nov; 55(11):1807-1821. PubMed ID: 26513129
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human platelets and polymorphonuclear leukocytes synthesize oxygenated derivatives of arachidonylethanolamide (anandamide): their affinities for cannabinoid receptors and pathways of inactivation.
    Edgemond WS; Hillard CJ; Falck JR; Kearn CS; Campbell WB
    Mol Pharmacol; 1998 Jul; 54(1):180-8. PubMed ID: 9658204
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Effects of anandamide on the activation and proliferation of hepatic stellate cells through cannabinoid-2 receptors].
    Liu HY; Yang Q; Duan RX; Zhang YW; Tang WX
    Zhonghua Gan Zang Bing Za Zhi; 2008 Jun; 16(6):430-4. PubMed ID: 18578993
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The endogenous cannabinoid, anandamide, activates the hypothalamo-pituitary-adrenal axis in CB1 cannabinoid receptor knockout mice.
    Wenger T; Ledent C; Tramu G
    Neuroendocrinology; 2003 Dec; 78(6):294-300. PubMed ID: 14688442
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anandamide-induced cell death in primary neuronal cultures: role of calpain and caspase pathways.
    Movsesyan VA; Stoica BA; Yakovlev AG; Knoblach SM; Lea PM; Cernak I; Vink R; Faden AI
    Cell Death Differ; 2004 Oct; 11(10):1121-32. PubMed ID: 15375383
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Control by the endogenous cannabinoid system of ras oncogene-dependent tumor growth.
    Bifulco M; Laezza C; Portella G; Vitale M; Orlando P; De Petrocellis L; Di Marzo V
    FASEB J; 2001 Dec; 15(14):2745-7. PubMed ID: 11687506
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of endocannabinoids in the regulation of luteinizing hormone and prolactin release. Differences between the effects of AEA and 2AG.
    Oláh M; Milloh H; Wenger T
    Mol Cell Endocrinol; 2008 Apr; 286(1-2 Suppl 1):S36-40. PubMed ID: 18308464
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dual effect of anandamide on rat placenta nitric oxide synthesis.
    Cella M; Leguizamón GF; Sordelli MS; Cervini M; Guadagnoli T; Ribeiro ML; Franchi AM; Farina MG
    Placenta; 2008 Aug; 29(8):699-707. PubMed ID: 18561998
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anandamide-induced cell death: dual effects in primary rat decidual cell cultures.
    Fonseca BM; Correia-da-Silva G; Teixeira NA
    Placenta; 2009 Aug; 30(8):686-92. PubMed ID: 19560819
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Endocannabinoids decrease neuropathic pain-related behavior in mice through the activation of one or both peripheral CB₁ and CB₂ receptors.
    Desroches J; Charron S; Bouchard JF; Beaulieu P
    Neuropharmacology; 2014 Feb; 77():441-52. PubMed ID: 24148808
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anandamide induces matrix metalloproteinase-2 production through cannabinoid-1 receptor and transient receptor potential vanilloid-1 in human dental pulp cells in culture.
    Miyashita K; Oyama T; Sakuta T; Tokuda M; Torii M
    J Endod; 2012 Jun; 38(6):786-90. PubMed ID: 22595113
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 5-lipoxygenase mediates docosahexaenoyl ethanolamide and N-arachidonoyl-L-alanine-induced reactive oxygen species production and inhibition of proliferation of head and neck squamous cell carcinoma cells.
    Park SW; Hah JH; Oh SM; Jeong WJ; Sung MW
    BMC Cancer; 2016 Jul; 16():458. PubMed ID: 27411387
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High levels of anandamide, an endogenous cannabinoid, block the growth of sheep preimplantation embryos by inducing apoptosis and reversible arrest of cell proliferation.
    Turco MY; Matsukawa K; Czernik M; Gasperi V; Battista N; Della Salda L; Scapolo PA; Loi P; Maccarrone M; Ptak G
    Hum Reprod; 2008 Oct; 23(10):2331-8. PubMed ID: 18614613
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The endocannabinoid anandamide induces apoptosis of rat decidual cells through a mechanism involving ceramide synthesis and p38 MAPK activation.
    Fonseca BM; Correia-da-Silva G; Teixeira NA
    Apoptosis; 2013 Dec; 18(12):1526-35. PubMed ID: 24048885
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification and functional characterization of brainstem cannabinoid CB2 receptors.
    Van Sickle MD; Duncan M; Kingsley PJ; Mouihate A; Urbani P; Mackie K; Stella N; Makriyannis A; Piomelli D; Davison JS; Marnett LJ; Di Marzo V; Pittman QJ; Patel KD; Sharkey KA
    Science; 2005 Oct; 310(5746):329-32. PubMed ID: 16224028
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anticancer activity of anandamide in human cutaneous melanoma cells.
    Adinolfi B; Romanini A; Vanni A; Martinotti E; Chicca A; Fogli S; Nieri P
    Eur J Pharmacol; 2013 Oct; 718(1-3):154-9. PubMed ID: 24041928
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cannabinoid receptor CB1 regulates STAT3 activity and its expression dictates the responsiveness to SR141716 treatment in human glioma patients' cells.
    Ciaglia E; Torelli G; Pisanti S; Picardi P; D'Alessandro A; Laezza C; Malfitano AM; Fiore D; Pagano Zottola AC; Proto MC; Catapano G; Gazzerro P; Bifulco M
    Oncotarget; 2015 Jun; 6(17):15464-81. PubMed ID: 26008966
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mead ethanolamide, a novel eicosanoid, is an agonist for the central (CB1) and peripheral (CB2) cannabinoid receptors.
    Priller J; Briley EM; Mansouri J; Devane WA; Mackie K; Felder CC
    Mol Pharmacol; 1995 Aug; 48(2):288-92. PubMed ID: 7651362
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.